Fortress Biotech
FBIO
$1.74
Share price
-3.33%
Change (1 day)
128.96%
Change (1 year)
Categories
Fortress Biotech (FBIO) - Cash on Hand
Cash on Hand as of December 2023 : $80.92 M
According to Fortress Biotech
's latest financial reports the company has $80.92 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Fortress Biotech - Cash on Hand chart (from 2011 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.17 B | -41.69% |
| 2021-12-31 | $0.30 B | 31.02% |
| 2020-12-31 | $0.23 B | 70.51% |
| 2019-12-31 | $0.13 B | 64.67% |
| 2018-12-31 | $83.11 M | -36.53% |
| 2017-12-31 | $0.13 B | 42.84% |
| 2016-12-31 | $91.68 M | -6.62% |
| 2015-12-31 | $98.18 M | 40.74% |
| 2014-12-31 | $69.76 M | -29.9% |
| 2013-12-31 | $99.52 M | 147.57% |
| 2012-12-31 | $40.19 M | 73.57% |
| 2011-12-31 | $23.16 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | $0.21 B | 167.47% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Advaxis ADXS | $4.88 M | -93.97% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $0.74 B | 817.25% | 🇺🇸 USA |